370 related articles for article (PubMed ID: 18551357)
1. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
Gabeta S; Norman GL; Gatselis N; Liaskos C; Papamichalis PA; Garagounis A; Zachou K; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2008 Sep; 28(5):501-11. PubMed ID: 18551357
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune liver diseases and antiphospholipid antibodies positivity: a meta-analysis of literature studies.
Ambrosino P; Lupoli R; Spadarella G; Tarantino P; Di Minno A; Tarantino L; Di Minno MN
J Gastrointestin Liver Dis; 2015 Mar; 24(1):25-34, 3 p following 34. PubMed ID: 25822431
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis.
Liaskos C; Rigopoulou E; Zachou K; Georgiadou S; Gatselis N; Papamihali R; Dalekos GN
J Autoimmun; 2005 May; 24(3):251-60. PubMed ID: 15848048
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
6. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases.
Zachou K; Liaskos C; Rigopoulou E; Gabeta S; Papamichalis P; Gatselis N; Georgiadou S; Dalekos GN
Clin Immunol; 2006 May; 119(2):203-12. PubMed ID: 16500150
[TBL] [Abstract][Full Text] [Related]
7. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6.
Xu B; Broome U; Ericzon BG; Sumitran-Holgersson S
Gut; 2002 Jul; 51(1):120-7. PubMed ID: 12077104
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases.
Himoto T; Yoneyama H; Kurokohchi K; Inukai M; Masugata H; Goda F; Haba R; Watanabe S; Senda S; Masaki T
Can J Gastroenterol; 2012 Mar; 26(3):125-9. PubMed ID: 22408762
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
11. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
12. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.
Boberg KM; Aadland E; Jahnsen J; Raknerud N; Stiris M; Bell H
Scand J Gastroenterol; 1998 Jan; 33(1):99-103. PubMed ID: 9489916
[TBL] [Abstract][Full Text] [Related]
13. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
Muratori P; Muratori L; Guidi M; Maccariello S; Pappas G; Ferrari R; Gionchetti P; Campieri M; Bianchi FB
Clin Exp Immunol; 2003 Jun; 132(3):473-6. PubMed ID: 12780695
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
15. Overlap syndromes among autoimmune liver diseases.
Rust C; Beuers U
World J Gastroenterol; 2008 Jun; 14(21):3368-73. PubMed ID: 18528934
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of antibodies to calreticulin of the IgA class in primary biliary cirrhosis: a possible role of gut-derived bacterial antigens in its aetiology?
Kreisel W; Siegel A; Bahler A; Spamer C; Schiltz E; Kist M; Seilnacht G; Klein R; Berg PA; Heilmann C
Scand J Gastroenterol; 1999 Jun; 34(6):623-8. PubMed ID: 10440614
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease.
Moreira RK; Revetta F; Koehler E; Washington MK
World J Gastroenterol; 2010 Jan; 16(4):453-7. PubMed ID: 20101770
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
19. Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.
Landi A; Weismuller TJ; Lankisch TO; Santer DM; Tyrrell DL; Manns MP; Houghton M
J Interferon Cytokine Res; 2014 Mar; 34(3):204-14. PubMed ID: 24168449
[TBL] [Abstract][Full Text] [Related]
20. IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis.
Schwarze C; Terjung B; Lilienweiss P; Beuers U; Herzog V; Sauerbruch T; Spengler U
Clin Exp Immunol; 2003 Aug; 133(2):283-9. PubMed ID: 12869036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
